A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer.
Women who eat red meat more than once a day double the risk of getting the most common form of breast cancer, doctors have found.
Normal aging of breast tissue lessens breast cancer risk, reports a new study by Mayo Clinic Cancer Center researchers published in the Nov. 15 issue of the Journal of the National Cancer Institute.
Younger women who eat more red meat may be at higher risk of a certain kind of breast cancer, perhaps because of hormonal residues in beef cattle and other factors, according to a published study.
Almost half of newly diagnosed breast cancer patients are found to have clinically significant emotional distress or symptoms of psychiatric disorders before treatment is begun, according to a new study published in the December 15, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
A diagnosis of breast cancer has taken on a new meaning in the past 10 years, as research has produced a host of new therapies and detection techniques, significantly improving long-term survival for women who have been fighting the disease.
A study at Washington University School of Medicine in St. Louis showed that in women whose initial breast biopsies revealed certain rare, yet benign breast conditions, more extensive follow-up surgical biopsies found cancer up to 25 percent of the time. Most of the cancers were invasive, meaning the tumors had penetrated normal breast tissue and would require treatment.
Despite an overall decline in invasive breast cancer in the United States in recent years, African-American women, particularly younger ones, have not seen a significant decline in their rates, according to researchers at the University of Pittsburgh. These findings, which are being presented at the American Public Health Association (AHPA) Annual Meeting in Boston, Nov. 4 ? 8, strongly suggest the need for additional research to understand why these differences persist and to determine whether avoidable or preventable factors account for these puzzling patterns, according to the investigators.
Doctors have created a first-ever computer tool to predict the risk of breast cancer returning in the same breast over a 10-year period in women who have had breast conserving surgery to remove only the cancer (lumpectomy), according to a study presented November 6, 2006, at the American Society for Therapeutic Radiology and Oncology’s 48th Annual Meeting in Philadelphia.
In this era of molecular medicine, controversy among cancer researchers is increasing as to whether the laboratory cells they study — and upon which human treatment is based — accurately reflect the biology of “real” tumors growing in a person’s body. Some argue that cancer cells that learn to live in a flat lab dish cannot reflect cancer in the body, but others say that without any other way to study cancer, they seem to have performed well.